We are glad that Isomorphic is helping advance the field and are able to match the level of performance we demonstrated at the ARDD conference in Copenhagen last August. In August, Deep Origin ...

Promega Corporation has introduced a new platform designed to help drug discovery scientists study some of the most challenging protein targets in living cells, enabling earlier and more reliable ...

Protai, an AI drug discovery startup, announced its participation in a series of major scientific conferences this spring, where it will present significant advances in its AIMS™ proteomics-aware-AI ...

Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

Twist Bioscience's Q1 growth was modest, due in large part to an air pocket in demand caused by a large NGS customer. Read ...

As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report ...

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of ...

Professor Paul Chirik leads a lab researching potential new catalysts for pharmaceutical and commercial applications.

QuantX Biosciences, Inc., a computationally driven drug discovery and development company using advanced modeling and high-performance computing to rapidly design and optimize oral small molecule ...

Key opportunities in the protein labeling market include increasing demand for site-specific tags in proteomics and drug development, the rise of AI tools for protein structure prediction, and the ...